▎ 5-Amino-1MQ Risach
Wetin na di risach bakgrɔn fɔ 5-Amino-1MQ?
insay di fil we de evolv fכ mεtabolik hεlth εn lכng layf risεch, fכ no ifektiv intavεnshכn dεm fכ adrεs mεtabolik dizכrd dεm εn delay ol ej stil bi wan sεntri sayɛns fכkus. Nikotinamid N-methyltransferase (NNMT) de sho hכy aktiviti insay adipos tisu εn liva. bay we i de mεtylet nikotinamid, i de ridyus in kכnvכshכn to nikotinamid adenine dinucleotide (NAD+). NAD+ na imכtant fכ sεlyul bεsal mεtabolism, εnεji prodakshכn, DNA ripa, εn signal path dεm. fכ mεnten in optimal lεvεl dεm implεnt fכ sεl dεm hεlth εn fכ kכmbat ol εn mεtabolik disfכnkshכn. Insay 2017, risechar dɛm na di Yunivasiti ɔf Tɛksas bin fɔs invɛstigat 5-Amino-1MQ we dɛn bin de luk fɔ we fɔ inhibit NNMT. Given NNMT in strɔng asosieshɔn wit fat ɛn tayp 2 dayabitis, di risach pipul dɛn hypothesize se fɔ blok NNMT kin pɔtɛnɛshɛl opin nyu avenyu fɔ trit fat ɛn in mɛtabolik kɔmplikeshɔn dɛm. Dis fכm di krichכl bakdrop fכ di 5-Amino-1MQ risεch.
Wetin na di mεkanism fכ akshכn fכ 5-Amino-1MQ?
inhibit sεvikal kεnsar sεl proliferashכn: 5MQ na sכmכl mכlikul inhibito fכ nikotinamid N-methyltransferase (NNMT) we de sho signifyant antiproliferativ ifekt pan di HeLa εpitεlial sεvikal kεnsar sεl layn, wit dis ifekt we de dipεnd pan kכnsantreshכn- εn tεm. NNMT na mεtabolik εnzym we de sho se di tכmכro de go bifo εn mεtastas. bay we i de inhεbit NNMT, i go bi se 5MQ de disrupt wan siriכs intasεlulyar mεtabolik path dεm we lεnk to tכmכro growth. fכ egzampl, 5MQ kin intafεr wit nikotinamid mεtabolism-rεlatεd signal path dεm. di imbalans insay di nikotinamid mεtabolism kin impכkt di sεl εnεji mεtabolism mכr, DNA ripa, εn כda prכsεs dεm, we de sכpres di kεnsar sεl proliferashכn. insay εkspεriεns, as 5MQ kכnsantreshכn de inkrεs εn tritmεnt dεryushכn de εkstεnd, HeLa sεl proliferashכn sho prכgrεsiv pronכns inhibishכn. כlsay na di sem tεm, dεn bin obsεv mכfכlכjik chenj dεm we inklud sεl shrinkεj, lכs fכ intasεlulyar adheshon, εn apoptotik bכdi dεm, we sho se 5MQ de indyuz apoptosis, we de sכpres sεl proliferashכn [1]..
Rεgulεshכn fכ Rilatεd Jin εn Protεin εksprεshכn: Fכlכ 5MQ tritmεnt fכ HeLa sεl dεm, mRNA lεvεl fכ ZEB1, SIRT1, εn CD16 inkrεs, we TWIST εn SERPIN1 mRNA lεvεl dεm dכn. kכmכnt, εksprεshכn fכ di כnkojεnik protin dεm fכsfo-Akt εn SIRT1 dεn dכn. dis jin dεm εn protin dεm de ple imכtant rol dεm fכ tumorigenesis εn prכgreshכn. fכ egzampl, TWIST εn SERPIN1 kin tכpikכl wit tכmכro invashכn εn mεtastas. bay we dεn de ridyus dεn εksprεshכn, 5MQ kin sכpres di invasiv εn mεtastas kεpabiliti dεm fכ di HeLa sεl dεm. pan tap we di mRNA lεvεl dεm fכ ZEB1 εn SIRT1 inkrεs, di εksprεshכn fכ di כnkojεnik protin SIRT1 dכn dכn. dis kin apin biכs 5MQ de afekt post-transkripshכnal rεguleshכn, inhεbit SIRT1 protin fכnshכn εn dat de afekt sεl proliferashכn εn sכvayvεns. fכsfכraylet Akt de ple imכtant rol fכ sεl sכvayvεns, proliferashכn, εn mεtabolik rεguleshכn. 5MQ in ridyusכn pan in εksprεshכn kin inhεbit kεnsar sεl proliferashכn εn sכvayv bay we i de blכk rilayt signal path dεm [1]..
Wetin na di aplikeshɔn dɛn fɔ 5-Amino-1MQ?
insay mεtabolik hεlth risεch, in kכr fכnshכn na fכ rεstכr sεlyul mεtabolik bεlε bay we i de inhεbit NNMT. NNMT de it nikotinamid (we na wan prεkursכr fכ NAD+) εn i de impכkt mεtil dכna mεtabolism, we 5-Amino-1MQ de blכk dis prכsεs: na wan an, i de ridyus nikotinamid mεtyleshכn kכnsכmshכn insay adiposyt dεm, we de εlevεt intasεlulyar NAD+ lεvεl dεm fכ aktibכt NAD8-dipεndεnt lכng layf jin dεm (lεk SIRT1) εn optimiz di maytochכndrial fכnshכn— na wan prכsεs we de mek lipolysis, inhibit lipojenεsis, εp fכ rεgεl di enεji mεtabolism insay adipos tisu, εn ridyus di εksyכs fεt akyumyuleshכn. na di כda say, i de εlεviet insulin rεsistεns bak we dεn kin si insay mεtabolik dizכrd bay we i de impruv insulin signal path sεnsitiviti, we i kin pכtεnshal indaykt rεgεl di hεpatik glukonεojεnεsis fכ εp fכ mεnten stebul bכdi glukכs lεvεl. fכ tכk di tru, in pכtεnshal impak pan gut maykrobayta de כnda invεstigeshכn, wit spεkulεshכn se i kin indaykt sכpכt כvala mεtabolik homכstasis bay we i de rεgεl maykrobial mεtabolik aktiviti (εgz., i de ridyus harmful mεtabolit prodakshכn).
insay kεnsar risεch, in aplikεshכn de fכs fכ tכk bכt di 'mεtabolik vulnerability' fכ di tכmכro sεl dεm. fכ mek di tכmכro sεl dεm go bifo kwik kwik wan, di tכmכro sεl dεm kin dip pan abnכmal aktv mεtabolik path dεm (lεk di Warburg ifekt), εn NNMT de hεvi εksprεs insay sכm tכmכro sεl dεm, we de sכpכt dεn mεtabolism. bay we i de inhεbit NNMT, 5-Amino-1MQ de disrupt di tכmכro sεl mεtabolism insay tu we dεm: fכs, i de ridyus di intasεlulyar NAD+ lεvεl dεm, i de impεr di enεji prodakshכn, we de mek i nכ infεkt εnεji εn bayosεntetik sabstεt dεm we nid fכ proliferashכn; sεkכn, i de impεr di yutilizeshכn fכ mεtil dכna dεm, we de disrupt epijεnik rεgεdyushכn prכsεs dεm lεk DNA mεtyleshכn insay tכmכro sεl dεm, we de sכpres jin εksprεshכn we de asai fכ proliferashכn εn mεtastas. apat frכm dat, i kin indaykt inhεbit di tכmכro growth εn spred bay we i de mכdulet mεtabolik fכktכ dεm na di tכmכro maykro envayroment, we de gi bεsis fכ εksplכr di tכmכro mεtabolik intavεnshכn stratεji dεm.
as fכndamεntכl risεch tul, i de sav as wan kכl mεtכd fכ dεsifεr NNMT in fysiolojikal fכnshכn dεm. rεsכch dεm kin prεsis blכk NNMT aktiviti we dεn de yuz 5-Amino-1MQ insay sεlyul כ animal mכdel fכ obsכv chenj dεm we de afta dat insay mεtabolik indikεtכ dεm. fכ egzampl, insay sεlyul εkspεriεns, fכ mכnitor NAD+ kכnsantreshכn, mεtil dכna lεvεl, εn di aktvכti fכ εnzym dεm we involv insay fεt asid sεntez kin klarify NNMT in spεsifi k rol insay sεlyul mεtabolism. insay animal mכdel dεm, we dεn kכmbayn wit tisu-spεsifi k sεmpl analisis, i de mek i ebul fכ εksplכr NNMT in tisu spεsifi k fכnshכn dεm—lεk in impak pan hεpatik mεtabolism we i de ol כ in rεgulεshכn fכ enεji saplai insay nyuron dεm. fכ tכk di tru, fכ leva di difrεnt rispכns dεm akraos sεl layn dεm (εgz., nכmal sεl dεm we de sho lכw sεnsitiviti vεrs pronכns rεspכns dεm na mεtabolik abnכmal כ tכmכro sεl dεm) kin εp fכ dεsifεr spεsifi k sεlyul mεtabolik mεkanism dεm, we de gayd sכbsεkvεnt tכgεt risεch.
insay di dכmεn dεm fכ mכsul hεlth εn kכgnishכn, in aplikεshכn de sεntrε pan di 'εnεji mεtabolism - sεlyul fכnshכn' rilayshכn. insay di mכsul hεlth risεch, di mכsul rεpa de dip pan di aktibכshכn εn proliferashכn fכ di sataylayt sεl dεm, we na prכsεs we nid fכ gi di mכsul dεm we de fכ di εnεji. —5-Amino-1MQ de protεkt sataylayt sεl aktibכshכn bay we i de mεnten di intasεlulyar NAD+ lεvεl dεm na di mכsul sεl dεm. di sem tεm, i de optimize di maytochכndrial fכnshכn fכ εnhans mכsul εnεji mεtabolism efyushכn, we de εliviet rεkכvri strεs pכst-mכsul injuri. i kin ridyus di oksidativ strεs bak na di mכsul tisu, we de protεkt di sεl dεm frכm di damej we di mεtabolik bayprכdukt dεm we pasmak kin mek. insay kכgnitiv risεch, di bren nyuron dεm de sho εkstrim hכy εnεji dimand, εn di dεklin NAD+ lεvεl dεm kכrelεt wit nyural fכnshכn dεklin. 5-Amino-1MQ de kip nyuronal NAD+ saplai bay we i de inhibit NNMT, we de sef di maytochכndrial fכnshכn εn ridyus nyuroinflameshכn. i kin infכlכw nyurotransmit mεtabolism bak (via NAD+-dipεndεnt εnzym dεm we involv insay nyurotransmitta sεntesis) fכ sכpכt kכgnitiv-rεlatεd nyuronal aktiviti (εgz., sεlyul fכnshכn insay lanin/mεmכri rijyכn dεm lεk di hipokamp), we de gi nכvel pεspεktiv fכ kכgnitiv fכnshכn mεntenans risεch.
Dɔn
as spεsifi k inhibito fכ nikotinamid N-methyltransferase (NNMT), 5-Amino-1MQ de sho kכr valyu akraos mכltipכl domεn dεm bay we i de tכk NNMT-rεgεl mεtabolik path dεm. i kin impruv fכ fat εn insulin rεsistεns bay we i de mεnten di NAD+ lεvεl, optimiz di maytochכndrial fכnshכn, εn rεstכr mεtabolik bεlε. i de tכk bak di mεtabolik vulnerabiliti dεm na di tכmכro sεl dεm, we de disrupt dεn enεji prodakshכn εn epijεnik rεguleshכn fכ inhεbit di tכmכro gro. pan tap dat, i de sav as risach tul fכ elucidate NNMT fכnshכn we i de sho pכtεnshal rol dεm fכ mכsul rεpa εn kכgnitiv mεntenans, we de gi ki dairekshכn fכ intavεnshכn stכdi dεm insay mεtabolik sik dεm, kεnsar, εn kכndishכn dεm we rilet.
Bɔt di pɔsin we rayt di buk
Di tin dɛn we wi dɔn tɔk bɔt ɔp, na ɔl di tin dɛn we Cocer Peptides dɔn du risach, ɛdit ɛn kɔmpilayt.
Sayɛns Jɔnal Author
Akar s na risachman we in wok de pe atɛnshɔn pan mɔlikul mɛkanism ɛn tritmɛnt intavɛnshɔn. i dכn kכntribyut fכ stכdi dεm we de invεstigat di rol we di εnzym dεm εn sכm mכlikul inhibito dεm de ple fכ rεgεl di sεl proliferashכn. in risach εnfaz di imכpכtants fכ tכk mεtabolik path dεm, lεk nikotinamid N-methyltransferase, fכ εksplכr nyu bayomεdikal stratεji dεm.Akar s dεn list am na di rεfrεns fכ saytεshכn [2].
